SLC38A2 and breast cancer: Of interest, SNAT2 was also strongly up-regulated by hypoxia in ER− breast cancer cells; thus, its role in triple-negative breast cancer, which is generally more hypoxic and glutamine-dependent (47), deserves further evaluation.